Skip to main content
  • This website sets cookies on your device. To find out more about how we use cookies please refer to our Privacy and Cookie Policy. By continuing to use the site, we’ll assume that you are content for us to set these on your device.
  • Close
Home > Prudential Regulation Authority > Solvency II: ORSA and the ultimate time horizon — non-life firms - SS26/15 UPDATE

Solvency II: ORSA and the ultimate time horizon — non-life firms - SS26/15 UPDATE

16 February 2017


This supervisory statement sets out the Prudential Regulation Authority’s (PRA) expectations of how non-life firms should identify and manage all risks to which their business could be exposed over the long and short term. This supervisory statement is of interest  to UK solo insurance firms within the scope of Solvency II that carry out non-life business, and to the Society of Lloyd’s in respect of each of their syndicates and in respect of outputs of the Lloyd’s internal model.

In forming supervisory judgements, the PRA draws on a broad set of quantitative and qualitative information to promote the safety and soundness of the firms it regulates, and to contribute to the securing of an appropriate degree of protection for policyholders.

Response to feedback to Consultation Paper (CP) 31/16

The updates to this statement and accompanying templates and LOG file was consulted on in Consultation Paper (CP) 31/16 ‘Updates to SS25/15 and SS26/15’ (see related links).

CP31/16 included updates to the supervisory statement in appendix 2, the templates in appendix 3 and LOG file in appendix 4. 

The PRA received two responses. The responses were not directly in relation to the specific proposals outlined within the CP. However, the PRA has made amendments to the updates to the supervisory statements to:

  • Clarify within the LOG file:
    • A conflict between the template and instructions on business plan loss ratios by Solvency II line of business (LoB), now clearly stating that this information is requested.
    • That kurtosis information within the market risk tab is not required.
    • All premium measures should be gross of acquisition costs and exclude insurance premium tax.
    • The instructions for PRE101, PRE102 and RES101, RES102 for columns C201 to C300 apply to template IM.03.02.01 only.
    • The instructions for business plan loss ratio - gross and net for premium risk apply to PRE209 / C101, C201 to C300 and C401 to C416.
    • The general comments for market risk apply to rows MKT101 to MK110, columns C201 to C201, C205 to C221, C301.
    • The output distribution to be reported for MKT301 is of the modelled annual return on a portfolio of equities (as opposed to an individual equity).
    • The risk-free rate referred to within MKT401 to MKT466 is the basic risk-free rate curves used in the calculation of the best estimate of the technical provisions.
    • A small number of inconsistencies with template IDs.
  • Amend the template to:
    • Remove ‘currency used for reporting’ as the LOG file specifically states reporting currency to be GBP.
    • Address a number of minor formatting issues within the template, including cell protection, column widths and the number of decimal points to display.

The changes made did not result in a change to PRA policy and therefore do not represent any additional burden to firms. 

Supervisory Statement

Solvency II: ORSA and the ultimate time horizon — non-life firms - SS26/15